103 related articles for article (PubMed ID: 16881973)
1. Stem cells show mixed results in MI patients.
Kahn J
J Interv Cardiol; 2006 Aug; 19(4):297-301. PubMed ID: 16881973
[No Abstract] [Full Text] [Related]
2. Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety.
Bartunek J; Vanderheyden M; Vandekerckhove B; Mansour S; De Bruyne B; De Bondt P; Van Haute I; Lootens N; Heyndrickx G; Wijns W
Circulation; 2005 Aug; 112(9 Suppl):I178-83. PubMed ID: 16159812
[TBL] [Abstract][Full Text] [Related]
3. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial.
Kang HJ; Lee HY; Na SH; Chang SA; Park KW; Kim HK; Kim SY; Chang HJ; Lee W; Kang WJ; Koo BK; Kim YJ; Lee DS; Sohn DW; Han KS; Oh BH; Park YB; Kim HS
Circulation; 2006 Jul; 114(1 Suppl):I145-51. PubMed ID: 16820564
[TBL] [Abstract][Full Text] [Related]
4. Lessons from the E-SIRIUS trial.
Schofer J
Ital Heart J; 2004 Jan; 5(1):1-2. PubMed ID: 15080572
[No Abstract] [Full Text] [Related]
5. Wanted! The best cell for cardiac regeneration.
Dimmeler S; Zeiher AM
J Am Coll Cardiol; 2004 Jul; 44(2):464-6. PubMed ID: 15261949
[No Abstract] [Full Text] [Related]
6. Designer stents and restenosis.
Vetrovec GW
Catheter Cardiovasc Interv; 2003 Oct; 60(2):179. PubMed ID: 14517921
[No Abstract] [Full Text] [Related]
7. Use of everolimus-eluting stent with a bioresorbable polymer coating for treatment of recurrent in-stent restenosis.
Honda H; Meguro T; Takizawa K; Isoyama S
J Invasive Cardiol; 2005 Feb; 17(2):112-5. PubMed ID: 15687539
[TBL] [Abstract][Full Text] [Related]
8. Preventing restenosis with stent drug coatings.
Belardi J
J Invasive Cardiol; 2002 Sep; 14(9):576-82. PubMed ID: 12369563
[No Abstract] [Full Text] [Related]
9. [Autologous stem cell therapy with surgical myocardial revascularization].
Durdu S; Cubukçuoğlu Deniz G; Akar AR
Anadolu Kardiyol Derg; 2009 Dec; 9(6):465-6. PubMed ID: 19965316
[No Abstract] [Full Text] [Related]
10. Very late [corrected] thrombosis of a sirolimus-eluting stent.
Henderson D; Gunalingam B
Catheter Cardiovasc Interv; 2006 Sep; 68(3):406-8. PubMed ID: 16892439
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience with a new biocompatible phosphorylcholine-coated coronary stent.
Zheng H; Barragan P; Corcos T; Siméoni JB; Favereau X; Roquebert PO; Guérin Y; Sainsous J
J Invasive Cardiol; 1999 Oct; 11(10):608-14. PubMed ID: 10745442
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients.
Miglionico M; Patti G; D'Ambrosio A; Di Sciascio G
Catheter Cardiovasc Interv; 2008 Apr; 71(5):600-4. PubMed ID: 18360849
[TBL] [Abstract][Full Text] [Related]
13. Drug-eluting stents are safe.
Garg S; Serruys P
Clin Pharmacol Ther; 2009 Aug; 86(2):130-2. PubMed ID: 19621006
[No Abstract] [Full Text] [Related]
14. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial.
Kang HJ; Kim HS; Zhang SY; Park KW; Cho HJ; Koo BK; Kim YJ; Soo Lee D; Sohn DW; Han KS; Oh BH; Lee MM; Park YB
Lancet; 2004 Mar; 363(9411):751-6. PubMed ID: 15016484
[TBL] [Abstract][Full Text] [Related]
15. Pilot study to evaluate the safety and feasibility of intracoronary CD133(+) and CD133(-) CD34(+) cell therapy in patients with nonviable anterior myocardial infarction.
Manginas A; Goussetis E; Koutelou M; Karatasakis G; Peristeri I; Theodorakos A; Leontiadis E; Plessas N; Theodosaki M; Graphakos S; Cokkinos DV
Catheter Cardiovasc Interv; 2007 May; 69(6):773-81. PubMed ID: 17394248
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial versus registry data--comparing apples and ORCHIDs.
Moliterno DJ
Catheter Cardiovasc Interv; 2006 Nov; 68(5):669-70. PubMed ID: 17039505
[No Abstract] [Full Text] [Related]
17. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
18. Drug-eluting stents for the prevention of restenosis: Standing the test of time.
Carter AJ
Catheter Cardiovasc Interv; 2002 Sep; 57(1):69-71. PubMed ID: 12203932
[No Abstract] [Full Text] [Related]
19. Comparison of human skeletal myoblasts and bone marrow-derived CD133+ progenitors for the repair of infarcted myocardium.
Agbulut O; Vandervelde S; Al Attar N; Larghero J; Ghostine S; Léobon B; Robidel E; Borsani P; Le Lorc'h M; Bissery A; Chomienne C; Bruneval P; Marolleau JP; Vilquin JT; Hagège A; Samuel JL; Menasché P
J Am Coll Cardiol; 2004 Jul; 44(2):458-63. PubMed ID: 15261948
[TBL] [Abstract][Full Text] [Related]
20. Is sirolimus better than paclitaxel? A review of the comparative data on drug-eluting stents.
Corbett SJ; Babic R; Cosgrave J; Sangiorgi GM; Colombo A
Cardiovasc Revasc Med; 2006; 7(3):159-64. PubMed ID: 16945823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
